奥美拉唑联合奥曲肽急诊治疗急性上消化道出血患者临床疗效及对PT、APTT、TT的影响

2021-05-06 19:22:57于鹏艳
中国医学创新 2021年9期

于鹏艳

【摘要】 目的:探讨奥美拉唑联合奥曲肽急诊治疗急性上消化道出血患者临床疗效及对PT、APTT、TT的影响。方法:选取2018年6月-2019年12月本院收治的急性上消化道出血患者180例,根据治疗方法不同将患者分为对照组和研究组,各90例。对照组应用奥美拉唑治疗,研究组应用奥美拉唑联合奥曲肽治疗。比较两组的临床治疗效果,出血时间,不良反应发生率以及凝血酶原时间(PT)、凝血活酶时间(APTT)、凝血酶时间(TT)。结果:治疗1周后,研究组的总有效率为91.1%,高于对照组的66.7%(P<0.05)。研究组出血时间短于对照组,肠胃不适、恶心呕吐以及腹痛的不良反应发生率均低于对照组,差异均有统计学意义(P<0.05)。治疗后,研究组的PT、APTT以及TT水平均低于对照组,差异均有统计学意义(P<0.05)。结论:在急性上消化道出血患者中应用奥美拉唑联合奥曲肽急诊治疗,可明显提高临床治疗效果,且不良反应发生率降低,出血时间明显缩短,同时降低了PT、APTT、TT水平,值得推广。

【关键词】 奥美拉唑 奥曲肽 急性上消化道出血 凝血酶原时间 凝血活酶时间 凝血酶时间

[Abstract] Objective: To explore the effect of Omeprazole combined with Octreotide on the clinical efficacy and PT, APTT, TT in patients with acute upper gastrointestinal hemorrhage. Method: A total of 180 patients with acute upper gastrointestinal bleeding admitted to our hospital from June 2018 to December 2019 were selected, they were divided into control group and study group according to random number table method, 90 cases in each group. The control group was treated with Omeprazole, the study group was treated with Omeprazole and Octreotide. The clinical effect, bleeding time, incidence of adverse reactions, prothrombin time (PT), activated partial thromboplastin time, (APTT) and thrombin time (TT) were compared between two groups. Result: After 1 week of treatment, the effective rate of the study group was 91.1% higher than 66.7% of the control group (P<0.05). The bleeding time in the study group was shorter than that in the control group, the incidence of adverse reactions such as gastrointestinal discomfort, nausea, vomiting and abdominal pain were lower than those in the control group, the differences were statistical significance (P<0.05). After treatment, PT, APTT and TT levels in the study group were lower than those in the control group, the differences were statistical significance (P<0.05). Conclusion: Omeprazole combined with octreotide in the emergency treatment of patients with acute upper gastrointestinal hemorrhage can significantly improve the clinical treatment effect, the incidence of adverse events in patients is reduced, bleeding time is significantly shortened, the level of PT, APTT, TT is reduced, which is worth promoting.

[Key words] Omeprazole Octreotide Acute upper gastrointestinal hemorrhage PT APTT TT

First-authors address: Chifeng Hospital, Chifeng 024000, China

doi:10.3969/j.issn.1674-4985.2021.09.028

急性上消化道出血是目前急診治疗中的常见疾病,主要表现为患者出现非静脉曲张性的上消化道出血[1-3]。该病的主要发病原因为急性胃黏膜发生病变、消化系统的溃疡以及吻合口的溃疡等[4-5]。急性上消化道出血患者患病后的主要临床特征为发病急,出血量较大,常规治疗对于此种病症的效果一直都不是特别明显,如果单独用药,患者的出血也很难控制[6-7]。奥美拉唑作为质子泵抑制剂,可以很好地治疗患者的上消化道出血情况,而且其效果极为明显,奥曲肽属于生长抑制类的药物,可以极好的降低患者内脏中血流量,于消化道出血具有很好的效果[8-10]。本研究探讨奥美拉唑联合奥曲肽急诊治疗急性上消化道出血患者临床疗效与对PT、APTT、TT的影响,现报道如下。

1 资料与方法

1.1 一般资料 选取2018年6月-2019年12月本院收治的急性上消化道出血患者180例。……

登录APP查看全文